Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

New horizons in the understanding of the causes and management of diabetic foot disease: report from the 2017 Diabetes UK Annual Professional Conference Symposium.

Clokie M, Greenway AL, Harding K, Jones NJ, Vedhara K, Game F, Dhatariya KK.

Diabet Med. 2017 Mar;34(3):305-315. doi: 10.1111/dme.13313. Epub 2017 Jan 23. Review.

PMID:
28029181
3.
4.

HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Greenway AL, Holloway G, McPhee DA, Ellis P, Cornall A, Lidman M.

J Biosci. 2003 Apr;28(3):323-35. Review.

5.

Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis.

Greenway AL, McPhee DA, Allen K, Johnstone R, Holloway G, Mills J, Azad A, Sankovich S, Lambert P.

J Virol. 2002 Mar;76(6):2692-702.

6.

HIV-1 Nef: a critical factor in viral-induced pathogenesis.

Greenway AL, Holloway G, McPhee DA.

Adv Pharmacol. 2000;48:299-343. Review. No abstract available.

PMID:
10987095
7.
8.

Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex.

McPhee DA, Greenway AL, Holloway G, Smith K, Deacon N, Pemberton L, Brew BJ.

J Neurovirol. 1998 Jun;4(3):291-300.

PMID:
9639072
9.

Serological detection of attenuated HIV-1 variants with nef gene deletions.

Greenway AL, Mills J, Rhodes D, Deacon NJ, McPhee DA.

AIDS. 1998 Apr 16;12(6):555-61.

PMID:
9583594
10.

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J.

Science. 1995 Nov 10;270(5238):988-91.

PMID:
7481804
11.

Constitutive and virus-induced interferon production by peripheral blood leukocytes.

Greenway AL, Hertzog PJ, Devenish RJ, Linnane AW.

Exp Hematol. 1995 Mar;23(3):229-35.

PMID:
7875240
12.

Immunolocalisation of interferon-alpha in hepatitis C patients and its correlation with response to interferon-alpha therapy.

Greenway AL, Hertzog PJ, Devenish RJ, Dudley FJ, McMullen GL, Linnane AW.

J Hepatol. 1994 Nov;21(5):842-52.

PMID:
7890902
13.

Detection of cells producing murine interferon-alpha using antipeptide antibodies.

Hwang SY, Greenway AL, McMullen GL, Hertzog PJ.

Immunol Cell Biol. 1994 Jun;72(3):234-40.

PMID:
8088862
14.
15.

Post-transcriptional regulation of interferon-alpha 4 subtype production by lymphoblastoid cells.

Greenway AL, Brandt ER, Hertzog PJ, Devenish RJ, Linnane AW.

Hematol Oncol. 1993 Jan-Feb;11(1):7-21.

PMID:
7686881
16.

Selective production of interferon-alpha subtypes by cultured peripheral blood mononuclear cells and lymphoblastoid cell lines.

Greenway AL, Overall ML, Sattayasai N, Rowley MJ, Hertzog PJ, McMullen GL, Cheetham BF, Marzuki S.

Immunology. 1992 Jan;75(1):182-8.

Supplemental Content

Loading ...
Support Center